CatalystEU/UK

ASTRAZENECA'S COPD DRUG SCORES TWO LATE-STAGE TRIAL WINS AS FULL DATA BOOSTS BLOCKBUSTER HOPES - CNBC

Late-stage trial wins and full data boost blockbuster hopes for AstraZeneca's COPD drug.

What changed

Late-stage trial wins and full data boost blockbuster hopes for AstraZeneca's COPD drug.

Why it matters

Late-stage trial wins and full data boost blockbuster hopes for AstraZeneca's COPD drug. — impact context not separately stored; see What changed.

Sources